Impairment of human neural crest cell migration by prolonged exposure to interferon-beta

Abstract

Human cell-based toxicological assays have been used successfully to detect known toxicants, and to distinguish them from negative controls. However, there is at present little experience on how to deal with hits from screens of compounds with yet unknown hazard. As a case study to this issue, we characterized human interferon-beta (IFNβ) as potential developmental toxicant affecting neural crest cells (NCC). The protein was identified as a hit during a screen of clinically used drugs in the ‘migration inhibition of neural crest’ (MINC) assay. Concentration–response studies in the MINC combined with immunocytochemistry and mRNA quantification of cellular markers showed that IFNβ inhibited NCC migration at concentrations as low as 20 pM. The effective concentrations found here correspond to levels found in human plasma, and they were neither cytostatic nor cytotoxic nor did they did they affect the differentiation state and overall phenotype of NCC. Data from two other migration assays confirmed that picomolar concentration of IFNβ reduced the motility of NCC, while other interferons were less potent. The activation of JAK kinase by IFNβ, as suggested by bioinformatics analysis of the transcriptome changes, was confirmed by biochemical methods. The degree and duration of pathway activation correlated with the extent of migration inhibition, and pharmacological block of this signaling pathway before, or up to 6 h after exposure to the cytokine prevented the effects of IFNβ on migration. Thus, the reduction of vital functions of human NCC is a hitherto unknown potential hazard of endogenous or pharmacologically applied interferons.Electronic supplementary materialThe online version of this article (doi:10.1007/s00204-017-1966-1) contains supplementary material, which is available to authorized users.

A structure–activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins

“…This way, noise could be filtered from signal in transcriptome data sets. This would probably not have been possible by use of classical transcriptomics technology, as used in one of our previous studies (Pallocca et al 2017) due to limiting resources. However, new highthroughput transcriptomics approaches (Yeakley et al 2017) make this approach possible, for instance in the context of the EU-ToxRisk project (Daneshian et al 2016).…”

Major changes of cell function and toxicant sensitivity in cultured cells undergoing mild, quasi-natural genetic drift

“…Identity of the used SP was confirmed by STR (Short Tandem Repeat) analysis as described previously (Pallocca et al 2017). Briefly, DNA samples from the SPs were prepared using a commercial kit (Puregene Cell Kit, Qiagen).…”

Reduced Aβ secretion by human neurons under conditions of strongly increased BACE activity

“…Identity of the LUHMES cells was authenticated by analysis as described previously (Pallocca et al . ). Briefly, DNA samples were prepared using a commercial kit (Puregene Cell Kit, Cat#158767, Qiagen, Hilden, Germany).…”

“…This cell line is not listed as a commonly misidentified cell line by the International Cell Line Authentication Committee (ICLAC). Identity of the LUHMES cells was authenticated by analysis as described previously (Pallocca et al 2017). Briefly, DNA samples were prepared using a commercial kit (Puregene Cell Kit, Cat#158767, Qiagen, Hilden, Germany).…”